{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:27:49Z","timestamp":1792787269547,"version":"4.5.0"},"reference-count":35,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004103","name":"Landspitali University Hospital","doi-asserted-by":"crossref","award":["A-2020-009"],"award-info":[{"award-number":["A-2020-009"]}],"id":[{"id":"10.13039\/501100004103","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Icelandic Research Fund","award":["207113-051"],"award-info":[{"award-number":["207113-051"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2022,12,9]]},"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Previous observational studies have yielded conflicting results on whether medication adherence differs between patients receiving warfarin and direct oral anticoagulants (DOACs). Importantly, no study has adequately accounted for warfarin dosing being continuously modified based on INR values while dosing of DOACs is fixed. We aimed to compare non-adherence between new users of apixaban, dabigatran, rivaroxaban and warfarin in a population-based cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>New users of apixaban, dabigatran, rivaroxaban and warfarin from 2014 to 2019 living in the Icelandic capital area were included. Non-adherence was defined as proportion of days covered below 80%. Inverse probability weighting was used to yield balanced study groups and non-adherence was compared using logistic regression. Factors associated with non-adherence were estimated using multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 1266 patients received apixaban, 247 dabigatran, 1566 rivaroxaban and 768 warfarin. The proportion of patients with non-adherence ranged from 10.5% to 16.7%. Dabigatran was associated with significantly higher odds of non-adherence compared with apixaban (OR 1.57, 95% CI 1.21 to 2.04, p&lt;0.001), rivaroxaban (OR 1.45, 95% CI 1.12 to 1.89, p=0.005) and warfarin (OR 1.63, 95% CI 1.23 to 2.15, p&lt;0.001). The odds of non-adherence were similar for apixaban, rivaroxaban and warfarin. Apart from the type of oral anticoagulants (OACs) used, female sex, hypertension, history of cerebrovascular accident and concomitant statin use were all independently associated with lower odds of non-adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Dabigatran was associated with higher odds of non-adherence compared with other OACs. Non-adherence was similar between apixaban, rivaroxaban and warfarin users. Female sex and higher comorbidity were associated with better medication adherence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2022-065700","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T10:47:21Z","timestamp":1672915641000},"page":"e065700","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of medication adherence to different oral anticoagulants: population-based cohort study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0943-2523","authenticated-orcid":false,"given":"Arnar B","family":"Ingason","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland"},{"name":"Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f3hann P","family":"Hreinsson","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Goteborg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigr\u00fan H","family":"Lund","sequence":"additional","affiliation":[{"name":"DeCODE Genetics, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnar S","family":"\u00c1g\u00fastsson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland"},{"name":"Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Rumba","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland"},{"name":"Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan\u00edel A","family":"P\u00e1lsson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland"},{"name":"Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indri\u00f0i E","family":"Reynisson","sequence":"additional","affiliation":[{"name":"Fjordur Health Care Center, Hafnarfjordur, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brynja R","family":"Gu\u00f0mundsd\u00f3ttir","sequence":"additional","affiliation":[{"name":"Department of Laboratory Hematology, Landspitali University Hospital, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e1ll T","family":"\u00d6nundarson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland"},{"name":"Department of Laboratory Hematology, Landspitali University Hospital, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar S","family":"Bj\u00f6rnsson","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Iceland, Reykjavik, Iceland"},{"name":"Department of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,1,5]]},"reference":[{"key":"2025121407054276000_13.1.e065700.1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000665"},{"key":"2025121407054276000_13.1.e065700.2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612"},{"key":"2025121407054276000_13.1.e065700.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.07.056"},{"key":"2025121407054276000_13.1.e065700.4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz405"},{"key":"2025121407054276000_13.1.e065700.5","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2017-000712"},{"key":"2025121407054276000_13.1.e065700.6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008773","article-title":"Safety and efficacy of novel oral anticoagulants versus warfarin in Medicare beneficiaries with atrial fibrillation and valvular heart disease","volume":"7","author":"Briasoulis","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2025121407054276000_13.1.e065700.7","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315307"},{"key":"2025121407054276000_13.1.e065700.8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ehjcvp\/pvw048","article-title":"Adherence with oral anticoagulation in non-valvular atrial fibrillation: a comparison of vitamin K antagonists and non-vitamin K antagonists","volume":"3","author":"S\u00f8rensen","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025121407054276000_13.1.e065700.9","doi-asserted-by":"crossref","unstructured":"Yao X , Abraham NS , Alexander GC , et al . Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation. J Am Heart Assoc 2016;5.doi:10.1161\/JAHA.115.003074","DOI":"10.1161\/JAHA.115.003074"},{"key":"2025121407054276000_13.1.e065700.10","doi-asserted-by":"crossref","DOI":"10.3390\/jpm8030022","article-title":"Warfarin: the end or the end of one size fits all therapy?","volume":"8","author":"Pirmohamed","year":"2018","journal-title":"J Pers Med"},{"key":"2025121407054276000_13.1.e065700.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-015-1983-z"},{"key":"2025121407054276000_13.1.e065700.12","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.7326\/M21-1474","article-title":"Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: a nationwide propensity score-weighted study","volume":"174","author":"Ingason","year":"2021","journal-title":"Ann Intern Med"},{"key":"2025121407054276000_13.1.e065700.13","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903126833"},{"key":"2025121407054276000_13.1.e065700.14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-83"},{"key":"2025121407054276000_13.1.e065700.15","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.139279"},{"key":"2025121407054276000_13.1.e065700.16","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1056\/NEJMoa1613792","article-title":"Mechanical or biologic prostheses for aortic-valve and mitral-valve replacement","volume":"377","author":"Goldstone","year":"2017","journal-title":"N Engl J Med"},{"key":"2025121407054276000_13.1.e065700.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034778"},{"key":"2025121407054276000_13.1.e065700.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011471"},{"key":"2025121407054276000_13.1.e065700.19","first-page":"440","article-title":"Primary nonadherence to oral anticoagulants in patients with atrial fibrillation: real-world data from a population-based cohort","volume":"24","author":"Rodriguez-Bernal","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"key":"2025121407054276000_13.1.e065700.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185642","article-title":"Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: a cohort study using primary care data in Germany","volume":"12","author":"Collings","year":"2017","journal-title":"PLoS One"},{"key":"2025121407054276000_13.1.e065700.21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.004517","article-title":"Major bleeding complications and persistence with oral anticoagulation in non-valvular atrial fibrillation: contemporary findings in real-life Danish patients","volume":"6","author":"Lamberts","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025121407054276000_13.1.e065700.22","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1096242"},{"key":"2025121407054276000_13.1.e065700.23","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2012.677419"},{"key":"2025121407054276000_13.1.e065700.24","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-310672"},{"key":"2025121407054276000_13.1.e065700.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"2025121407054276000_13.1.e065700.26","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12845"},{"key":"2025121407054276000_13.1.e065700.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.03.023"},{"key":"2025121407054276000_13.1.e065700.28","first-page":"1319","article-title":"Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-na\u00efve nonvalvular atrial fibrillation","volume":"22","author":"Brown","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"2025121407054276000_13.1.e065700.29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1185\/03007995.2015.1077213","article-title":"Pharmacy quality alliance measure: adherence to non-warfarin oral anticoagulant medications","volume":"31","author":"Crivera","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"2025121407054276000_13.1.e065700.30","first-page":"1054","article-title":"Adherence to a novel oral anticoagulant among patients with atrial fibrillation","volume":"21","author":"Zhou","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"2025121407054276000_13.1.e065700.31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5993\/AJHB.44.2.10","article-title":"Social risk factors for medication nonadherence: findings from the cardia study","volume":"44","author":"Oates","year":"2020","journal-title":"Am J Health Behav"},{"key":"2025121407054276000_13.1.e065700.32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210"},{"key":"2025121407054276000_13.1.e065700.33","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"Konstantinides","year":"2014","journal-title":"Eur Heart J"},{"key":"2025121407054276000_13.1.e065700.34","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/S2352-3026(15)00073-3","article-title":"Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial","volume":"2","author":"Onundarson","year":"2015","journal-title":"Lancet Haematol"},{"key":"2025121407054276000_13.1.e065700.35","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1182\/blood.2020008698","article-title":"Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study","volume":"137","author":"Oskarsdottir","year":"2021","journal-title":"Blood"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2022-065700","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T15:05:53Z","timestamp":1765724753000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2022-065700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,5]]},"published-print":{"date-parts":[[2023,1]]}},"alternative-id":["10.1136\/bmjopen-2022-065700"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2022-065700","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}